Abstract:We present an unusual case of antiphospholipid syndrome (APS) in a 31-year-old female patient exhibiting neuropsychiatric manifestations, followed by a subsequent thromboembolic stroke. APS is characterized by antiphospholipid antibodies leading to a prothrombotic state and an increased risk of thrombotic events. While the neurological involvement in APS typically presents with thrombotic events, antiphospholipid antibodies may also directly interact with neural tissue, causing immediate pathogenic effects that disrupt normal function. Neuropsychiatric manifestations in APS are rare but have been documented previously, including cases of psychosis and hallucinations. The timely recognition of APS in patients with neuropsychiatric symptoms is crucial for appropriate management and the prevention of further complications. The reported patient displayed aggressive, bizarre, and erratic behavior upon admission to the psychiatric unit, followed by the development of right-sided facial droop and weakness. Imaging studies revealed stenosis and partial occlusion of the left middle cerebral artery (MCA), and a repeat scan showed a known left MCA territory infarct with increasing hypodensity in specific brain regions. Notably, the patient exhibited multiple purpuric ecchymoses on bilateral upper extremities, raising suspicion of a hypercoagulable state. Laboratory investigations detected elevated levels of anticardiolipin IgG and beta-2 glycoprotein 1 IgG, along with a positive antinuclear antibody. The presence of a patent foramen ovale was also confirmed through echocardiography. This case emphasizes the importance of early APS recognition in patients with neuropsychiatric symptoms, facilitating appropriate intervention and improved outcomes. Further research is warranted to elucidate the underlying pathophysiological mechanisms connecting APS to neuropsychiatric manifestations, enabling enhanced understanding and refined management of this intricate condition.

Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage

Neurologic Manifestations of the Antiphospholipid Syndrome - an Update

Arterial Vasculopathy from Small to Large Vessels in a Neuroradiological Perspective

'Non-Criteria' Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered

Antiphospholipid Antibodies in Mental Disorders

Elucidating the Neuropsychiatric Phenomena of Antiphospholipid Syndrome in a 31-Year-Old Female

Case Report of Antiphospholipid Antibody Syndrome and Literature Review

Insights into Molecular Mechanisms and Clinical Manifestations

Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome

Targeting thromboinflammation in antiphospholipid syndrome

Prevalence, risk factors, and prognosis of central nervous system manifestations in antiphospholipid syndrome

Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts

Audiovestibular Dysfunction Related to Anti-Phospholipid Syndrome: A Systematic Review

Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome

Antiphospholipid Syndrome: a Survey of Clinical Characters in Ten Cases

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?

An update on inflammation in antiphospholipid syndrome

Patterns of Cerebrovascular Accidents in Antiphospholipid Syndrome

Can complement activation be the missing link in antiphospholipid syndrome?

Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management